Tuesday was the day the AI economy priced itself end to end. From Asia’s open to the US session, every layer showed up with a number attached — the silicon roadmap got dated, the mega-deals fused into equity, sovereignty got contested on two continents, and both the harms and the science scaled. One thing that did not arrive: Anthropic’s S-1.
The silicon layer got a roadmap
- ASML dates the ceiling. ASML, TSMC, Samsung and Intel each committed the same day to a 6→12-inch photomask transition for High-NA EUV — the fix for the reticle limit on AI-chip size, with TSMC in high-volume from 2030. The AI buildout published its lithography roadmap through 2033. Our take →
- The host CPU flips to Arm. Arm’s Neoverse CSS N4 lets hyperscalers spin custom server silicon fast; it cites IDC that Arm rack-scale servers have overtaken x86 as the dominant accelerated-computing platform. Our take →
- Memory taps the market. Longsys priced a ~$903M Hong Kong listing (memory modules, +136% H1 revenue) — capital repricing the unglamorous supply layer. Our take →
- Edge and defense. Japan’s EdgeCortix deepened a Kawasaki tie for AI aerial-defense silicon — small dollars, but sovereign edge-AI is a distinct axis. Our take → (Korea’s SEMIFIVE also began volume-producing an inference chip on Samsung 4nm.)
Who’s funding whom — and how
- Mistral → €3B. Europe’s open-weight champion raised at >€21B, led by Samsung with Nvidia and ASML on the cap table — the chip supply chain and the EU state co-financing a sovereign lab. Our take →
- Qualcomm × Amazon. A multi-gen custom-inference-silicon deal for AWS, structured as a warrant that vests as Amazon buys — up to a $60B threshold (a vesting ceiling, not committed spend). The purchase-vested warrant is the new architecture of AI mega-deals. Our take →
- Anthropic walks. It completed due diligence on Israeli startup Decart and walked from a ~$6B deal — keeping the cash for compute weeks before its IPO. Discipline is the signal. Our take →
- Is the capex durable? Jensen Huang called NVIDIA compute “durable, rentable, revenue-generating”; Michael Burry says the depreciation math flatters the books. The debate under every deal above. Our take →
Sovereignty and the stack
- OpenAI → Malaysia. OpenAI became an anchor customer of Australia’s Firmus for compute at two Malaysian AI-factory sites — the same country weighing Huawei for its sovereign cloud now hosts Western-stack frontier compute. Our take →
- Palantir + Nebius. A “complete sovereign AI stack” — Palantir naming a preferred compute partner to fight hyperscalers on the one axis they can’t concede: customer-controlled data and models. Our take →
- OpenAI licenses India. Within 48 hours it signed both dominant English publishers (Times Group, then the Indian Express Group) — attribution in lieu of a fee: license the willing while the ANI suit runs. Our take →
Who watches the agents
- AI’s offense gets cheap. Researchers say that working with AI they found a zero-click WeChat worm and wrote the first exploit in about two days (Tencent has patched it) — the cost curve of offensive security, collapsing. Our take →
- Meta’s ad channel fails. A watchdog found Meta ran hundreds of AI-generated child-abuse ads, placed via authorized Chinese resellers — an ad-monetization and governance failure with EU/UK regulatory exposure. Our take →
And a grace note
- DeepMind’s AlphaGenome Atlas. A ~1-petabyte precomputed map of predicted effects for ~9 billion DNA variants, free for academics with a paid Cloud path — the AlphaFold-Database playbook run on the genome (predictive, explicitly not clinical). Our take →
By the numbers
€3B Mistral raise · $60B Qualcomm–Amazon warrant ceiling · $903M Longsys listing · ~9B DNA variants mapped · 0 Anthropic S-1s filed (still watching)
The bottom line. Capital, silicon, and sovereignty all moved at once — the AI economy is being priced layer by layer, deals are fusing supply and equity into single instruments, and the harms and the science are scaling as fast as the money.
Wider frame: the Map of AI Redrawn and the week’s five through-lines.
Not investment advice. Several items are single-source or developing reports (Mistral, Qualcomm–Amazon terms, the Meta findings are a watchdog’s); the $60B is a warrant-vesting threshold, not committed spend; the WeChat bug is patched; AlphaGenome’s outputs are predictions, not clinical calls.
Sources: fourweekmba.com · fourweekmba.com · fourweekmba.com · fourweekmba.com · fourweekmba.com









